Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury

Annals of Thoracic Surgery

Volumn 79, Issue 4, 2005, Pages 1189-1195

  Reece, T Brett ^a,b   Laubach, Victor E ^a   Tribble, Curtis G ^a   Maxey, Thomas S ^a   Ellman, Peter I ^a   Warren, Patrick S ^a   Schulman, Andrew M ^a   Linden, Joel ^a   Kern, John A ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2A RECEPTOR AGONIST; MYELOPEROXIDASE; TIOPRONIN; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; ANTIOXIDANT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; OXYGEN; PEROXIDASE; PURINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART DISEASE; HEART OUTPUT; HEART PROTECTION; HEMODYNAMICS; LEUKOCYTE ACTIVATION; LUNG PERFUSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG POTENTIATION; HEART; LUNG; METABOLISM; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIAC OUTPUT; CYCLOHEXANECARBOXYLIC ACIDS; HEART; LUNG; NEUTROPHIL ACTIVATION; OXYGEN; PEROXIDASE; PURINES; RABBITS; REACTIVE OXYGEN SPECIES; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY;

EID: 20144389389     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.09.038     Document Type: Article

References (34)

1. R.C. King, O.A. Binns, F. Rodriguez Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 2000 1681 1685
2. S. Alam, K.M. Chan Noninfectious pulmonary complications after organ transplantation Curr Opin Pulm Med 2 1996 412 418
3. S.M. Fiser, I.L. Kron, S. McLendon Long Early intervention after severe oxygenation index elevation improves survival following lung transplantation J Heart Lung Transplant 20 2001 631 636
4. K.R. McCurry, R.J. Keenan Controlling perioperative morbidity and mortality after lung transplantation for pulmonary hypertension Semin Thorac Cardiovasc Surg 10 1998 139 143
5. P. Sorkine, A. Setton, P. Halpern Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration Crit Care Med 23 1995 1377 1381
6. R. Palazzo, A. Hamvas, T. Shuman Injury in nonischemic lung after unilateral pulmonary ischemia with reperfusion J Appl Physiol 72 1992 612 620
7. A.A. Weinbroum, E. Hochhauser, V. Rudick Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion J Trauma 43 1997 627 633
8. M.D. Okusa, J. Linden, T. Macdonald, L. Huang Selective A2A adenosine receptor activation reduces ischemia- reperfusion injury in rat kidney Am J Physiol 277 1999 F404 F412
9. S.D. Ross, C.G. Tribble, J. Linden Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation J Heart Lung Transplant 18 1999 994 1002
10. 2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord Ann Thorac Surg 72 2001 1245 1250
11. G.W. Sullivan, J.M. Rieger, W.M. Scheld Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists Br J Pharmacol 132 2001 1017 1026
12. J.A. McPherson, K.G. Barringhaus, G.G. Bishop Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model Arterioscler Thromb Vasc Biol 21 2001 791 796
13. M.D. Okusa, J. Linden, L. Huang A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion Am J Physiol Renal Physiol 279 2000 F809 F818
14. G.W. Sullivan, J. Linden, B.L. Buster, W.M. Scheld Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram J Infect Dis 180 1999 1550 1560
15. D.C. Cassada, C.G. Tribble, A.K. Kaza Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion Surgery 130 2001 230 235
16. K. Tanonaka, T. Iwai, K. Motegi, S. Takeo Effects of N-(2- mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfused heart Cardiovasc Res 57 2003 416 425
17. Y.T. Xuan, X.L. Tang, S. Banerjee Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits Circulation Res 84 1999 1095 1109
18. D.C. Cassada, C.G. Tribble, V.E. Laubach An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion J Vasc Surg 34 2001 482 488
19. M. Messent, M.J. Griffiths, G.J. Quinlan Ischaemia-reperfusion injury in the rat is modulated by superoxide generation and leads to an augmentation of the hypoxic pulmonary vascular response Clin Sci 90 1996 47 54
20. M.B. Grisham, D.N. Granger Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia with reperfusion Clin Chest Med 10 1989 71 81
21. T. Yamada, N. Murase, T. Maeda Protective effect of TNF-α and IL-1β inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation Transplant Proc 30 1998 2638
22. M.J. Shaw, H. Shennib, N. Bousette Effect of endothelin receptor antagonist on lung allograft apoptosis and NOSII expression Ann Thorac Surg 72 2001 386 390
23. M.J. Shaw, H. Shennib, L. Tayara Endothelin receptor antagonist SB209670 decreases lung allograft apoptosis and improves lung graft function after prolonged ischemia J Cardiovasc Pharmacol 36 2000 S209 S211
24. D.M. Chang, K. Hsu, Y.A. Ding, C.H. Chiang Interleukin-1 in ischemia-reperfusion acute lung injury Am J Respir Crit Care Med 156 1997 1230 1234
25. D.M. Guidot, A.D. Kitlowski, B.M. Hybertson, J.E. Repine Mitochondrial antioxidant function is a potential mechanism for organ differences in interleukin-1-mediated tolerance to oxidative injury Am J Med Sci 318 1999 308 315
26. T. Kadokami, C. Frye, B. Lemster Anti-tumor necrosis factor-α antibody limits heart failure in a transgenic model Circulation 104 2001 1094 1097
27. A. Blum, H. Miller Pathophysiological role of cytokines in congestive heart failure Annu Rev Med 52 2001 15 27
28. C.S. Long The role of interleukin-1 in the failing heart Heart Fail Rev 6 2001 81 94
29. B.S. Cain, D.R. Meldrum, C.A. Dinarello Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function Crit Care Med 27 1999 1309 1318
30. C. Di Filippo, M. D'Amico, R. Marfella Endothelin-1 receptor antagonists reduce cardiac electrical instability induced by high glucose in rats Naunyn Schmiedebergs Arch Pharmacol 366 2002 193 197
31. J. Marin-Garcia, M.J. Goldenthal, G.W. Moe Selective endothelin receptor blockade reverses mitochondrial dysfunction in canine heart failure J Card Fail 8 2002 326 332
32. J.M. Pearl, D.P. Nelson, C.J. Wagner Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation Ann Thorac Surg 72 2001 565 570
33. K.A. Kaminski, T.A. Bonda, J. Korecki, W.J. Musial Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury Int J Cardiol 86 2002 41 59
34. A. Suessenbacher, A. Lass, B. Mayer, F. Brunner Antioxidative and myocardial protective effects of L-arginine in oxygen radical-induced injury of isolated perfused rat hearts Naunyn Schmiedebergs Arch Pharmacol 365 2002 269 276